Saturday, 14 December 2019

Century Medical gets Japanese nod for Glider catheter

22 April 2013 | News | By BioSpectrum Bureau

TriReme receives approval in Japan to market Glider Catheter

TriReme receives approval in Japan to market Glider Catheter

TriReme receives approval in Japan to market Glider Catheter

‎Singapore: TriReme Medical's Japanese partner, Century Medical, has received Shonin approval for Glider PTCA catheter, which is indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion.

Combining a skived tip and a unique braided shaft, Glider is the world's only torqueable PTCA catheter and is designed to assist physicians in treating the most challenging cases such as bifurcations and highly stenosed lesions.

"We are proud to receive this regulatory approval for our highly differentiated Glider PTCA catheter," stated Dr Eitan Konstantino, CEO and president, TriReme. "We are looking forward to working closely with our partner, CMI. This milestone represents yet another concrete step in our strategic focus on the important Asian markets."

"Japanese cardiologists are well known for treating the most complex vascular disease," explained Akira Hoshino, president and CEO, CMI. "With its unique technology, Glider is designed to cross through tight lesions and provide improved outcomes where other balloons are challenged. Glider represents the first product, with others to follow, in our strategic partnership that will allow us to bring TriReme's cutting edge and high quality devices to Japan."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls